Nota: se requiere una receta válida para todos los medicamentos con receta.
Xultophy® Pluma precargada para la diabetes de tipo 2
Sitewide Super Sale - Get 15% off when you buy 3 or more of the same product. Just use the code LESS15 at checkout.
Coupon code cannot be combined with other offers. Sale applies to all products originating from Canada. Maximum allowable quantity equal to a 90 day supply per single order.
$324.00
Ahorra


This fixed-dose combination pairs insulin degludec with liraglutide to improve blood sugar in adults with type 2 diabetes. The overview below explains how the pen works, safe use, storage, and ways to access it, even without insurance.
What Xultophy Is and How It Works
Xultophy® combines an ultra–long-acting basal insulin (insulin degludec) with a GLP-1 receptor agonist (liraglutide) in one daily pen. It provides background insulin while enhancing glucose-dependent insulin secretion and slowing gastric emptying. Access is available with US delivery from Canada for eligible prescriptions. CanadianInsulin.com is a prescription referral platform. We verify prescriptions with your prescriber when required, and licensed Canadian pharmacies dispense your order.
This insulin degludec liraglutide prefilled pen helps lower fasting and post-meal glucose when used with diet and exercise. The combination may reduce the number of separate injections compared with taking the two components individually. Use only as directed by a healthcare professional, and review the full prescribing information before starting.
Who It’s For
This treatment is indicated for adults with type 2 diabetes who need additional glycemic control despite diet, exercise, or prior therapy. It is not for type 1 diabetes or for treating diabetic ketoacidosis. People with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should not use this therapy. It is not recommended for pediatric patients, and it has not been studied in combination with another GLP-1 receptor agonist.
Those switching from a basal insulin or from a GLP-1 agent should follow the labeled initiation and titration guidance. See broader options in our Diabetes de tipo 2 colección.
Posología y utilización
Inject once daily at the same time each day, with or without meals. Administer subcutaneously in the abdomen, thigh, or upper arm. Rotate injection sites within the same region to reduce skin changes. Never share a pen, even if a new needle is used. Do not mix with other insulins or use in an insulin pump.
The degludec liraglutide injection 100/3.6 is titrated based on fasting blood glucose and clinical response. Start and adjust only as described in the official label and by the prescriber. Use a new sterile pen needle for each injection, and confirm the dose on the dial before pressing the injection button fully.
Fortalezas y formas
The product is supplied as a prefilled FlexTouch device. Common presentations include Xultophy 100/3.6 mg/mL 3 mL pens. Packs may include multiple pens depending on market availability. Actual supply configurations can vary by pharmacy and jurisdiction.
For a broader view of long-acting options and devices, browse our Productos de insulina.
Dosis omitida y momento oportuno
If a dose is missed, take it when remembered during waking hours and then resume the usual once-daily schedule. Do not take extra doses or double up on the same day. If uncertain about timing, follow the official label or ask a healthcare professional. Monitor glucose more often after a missed dose.
Almacenamiento y viaje
Unopened pens should be stored refrigerated and protected from light. Do not freeze, and discard any pen that has been frozen. After first use, keep the pen at room temperature or refrigerated as directed in the label, away from heat and direct sunlight. Keep the cap on between uses, and remove the needle after each injection. Keep out of reach of children.
For travel, carry pens in hand luggage with a copy of the prescription and supplies for needles and disposal. Use an insulated case to avoid temperature excursions. If your trip involves long flights or warm climates, plan ahead for storage. Pharmacies and couriers use temperature-controlled handling when required to protect medicine integrity.
Manipulación de bolígrafos y eliminación de objetos punzantes
The Xultophy FlexTouch pen is designed for single-patient use. Read the Device Instructions for Use in the package before the first injection. If uncertain, practice with a demo device in clinic or review an illustrated tutorial.
- Check the label and the dose counter
- Attach a new needle and remove both caps
- Prime the pen per label before the first daily injection
- Select the prescribed dose with the dial
- Inject into the recommended site and keep the needle in place briefly
- Remove the needle and dispose of it safely
See our stepwise overview in the Guía de la pluma de insulina. Dispose of used needles and pens in an FDA-cleared sharps container or a puncture-resistant household container per local regulations.
Beneficios
This medicine offers convenience by combining basal insulin with a GLP-1 receptor agonist in one daily injection. It may reduce the number of separate injections and simplify titration with a single dose dial. The prefilled device helps streamline daily routines and supports adherence alongside structured diet and activity plans.
Efectos secundarios y seguridad
- Náuseas o vómitos
- Diarrea o estreñimiento
- Disminución del apetito
- Dolor de cabeza
- Reacciones en el punto de inyección
- Cold-like symptoms
Serious risks can include pancreatitis, gallbladder disease, acute kidney injury, severe gastrointestinal effects, and a risk of thyroid C-cell tumors associated with the GLP-1 component. Hypoglycemia can occur, especially if used with other glucose-lowering agents. Seek urgent care for symptoms of severe allergic reactions. For a deeper overview, read our Side Effects Guide and the official label.
Interacciones medicamentosas y precauciones
Agents that lower or raise blood glucose can change insulin needs, including corticosteroids, some diuretics, hormones, and certain antipsychotics. Alcohol may increase the risk of hypoglycemia or hyperglycemia. Beta-blockers can mask signs of low blood sugar. The GLP-1 component may slow gastric emptying, which can affect absorption of some oral medicines. Avoid combining with another GLP-1 receptor agonist unless instructed by a prescriber. Always review all medicines, vitamins, and supplements with a clinician.
Qué esperar con el tiempo
Glucose patterns generally improve gradually as the dose is titrated according to response and safety. Some gastrointestinal effects may occur when starting and often lessen with continued use. Keep consistent meal timing and monitoring. Record fasting and pre-meal readings to support clinical adjustments. Follow scheduled follow-ups and laboratory assessments as recommended by the prescriber.
Comparar con alternativas
Another fixed-ratio option pairs glargine with lixisenatide in Soliqua® Pens. An alternative GLP-1/GIP agent for type 2 diabetes is the Mounjaro® KwikPen. Choice depends on prior therapy, glycemic goals, tolerability, and clinician guidance.
Precios y acceso
Canadian pricing reflects the dispensing pharmacy’s rates and may differ by pack size and supply. To review options and the Xultophy prefilled pen price, check the product page for current details. For eligible prescriptions, fulfillment supports US delivery from Canada. If looking to buy Xultophy Prefilled Pen, submit a valid prescription and complete the required intake.
Self-pay buyers often compare cash price with insurance copays to decide the most affordable route. Out of pocket expenses vary by quantity and needle needs. For periodic coupon events, visit our Promociones page. Encrypted checkout is used to protect payment information.
Disponibilidad y sustituciones
Supply can vary by manufacturer lots and pharmacy inventory. If a specific pack size is unavailable, a prescriber may recommend an appropriate alternative or an adjusted quantity of pens. Therapeutic substitutions, if needed, should be made only by the prescriber after review of clinical history and goals.
Adecuación al paciente y consejos para ahorrar costes
This therapy may suit adults who require basal support plus incretin-based effects and prefer one daily pen. It may not be suitable for patients with certain thyroid tumors, active pancreatitis, or those requiring complex mealtime insulin regimens. Cost planning tips include multi-month fills when appropriate, aligning refill reminders with glucose log reviews, and combining pen orders with compatible needles to reduce separate fees. Explore broader options in Control de la glucemia when discussing choices with a prescriber.
Preguntas para su médico
- Is this combination appropriate given current A1C and fasting readings?
- How should titration proceed if morning glucose remains above target?
- What symptoms suggest hypoglycemia, and how should they be treated?
- Are there medicines I take that could affect glucose or mask lows?
- What monitoring schedule and follow-up labs are recommended?
- How should I store pens during travel and hot weather?
Fuentes autorizadas
Información para prescribir en EE.UU. | DailyMed Monograph | Ministerio de Sanidad de Canadá DPD
Ready to proceed? You can place your order with CanadianInsulin for US delivery from Canada, supported by cold-chain shipping when required by the product. This information is educational and not a substitute for medical advice; always consult a healthcare professional and the official label.
Envío urgente - desde $25.00
El envío con este método tarda entre 3 y 5 días
Los precios:
- Productos envasados en seco $25.00
- Productos envasados en frío $35.00
Envío estándar - $15.00
El envío con este método tarda entre 5 y 10 días
Los precios:
- Productos envasados en seco $15.00
- No disponible para productos envasados en frío
How this combo works
Xultophy combines basal insulin with a GLP-1 receptor agonist to address fasting and post-meal glucose through complementary mechanisms. The insulin component supplies steady background coverage, while the incretin component enhances glucose-dependent insulin secretion and slows gastric emptying. Together, they can help improve overall glycemic patterns when used with diet, activity, and regular monitoring. Review the Prescribing Information for full details on mechanisms and risks before starting therapy.
Using with mealtime insulin
This combination has not been established for routine use with prandial insulin. Some patients may require a separate mealtime insulin, but that decision should be made by a clinician who can assess glucose patterns and risks. Adding multiple injectables can increase hypoglycemia risk and may complicate titration. If your prescriber recommends changes, follow the label and monitoring plan closely to support safety.
Pen needles and compatibility
Most universal pen needles that meet ISO standards are compatible with FlexTouch-style devices. Use a new, sterile needle for each injection. Select a needle length based on individual factors and professional advice. Do not store the pen with a needle attached. Dispose of used needles in an approved sharps container to reduce needlestick risk. If unsure which needles fit the device, ask a pharmacist for guidance.
Managing nausea at start
Gastrointestinal effects such as nausea can occur when initiating a GLP-1–containing therapy like Xultophy. Eating smaller meals, avoiding high-fat foods, and staying hydrated may help. Nausea often lessens over time as the body adapts, but persistent or severe symptoms warrant contact with a healthcare professional. Never change your dose without prescriber direction. Report signs of pancreatitis, such as severe and persistent abdominal pain, promptly.
Refrigeration and travel
Unopened pens should be refrigerated and kept away from light. Do not freeze. After first use, store as directed on the label and avoid extreme heat. For air travel, keep pens in carry-on luggage with prescription documentation. Consider an insulated case and plan for time away from refrigeration. Remove the needle after each injection. If temperature excursions occur, consult a pharmacist before using the pen again.
Use in kidney disease
Renal function can influence tolerability of GLP-1–containing therapies, and insulin needs may vary with changes in kidney status. The product has been used in patients with chronic kidney disease, but caution is advised, especially if gastrointestinal effects lead to dehydration. Discuss your renal history and recent lab results with a clinician before starting or adjusting therapy. Follow monitoring guidance and report concerning symptoms promptly.
Boxed warning details
This medicine carries a boxed warning related to the GLP-1 component for risk of thyroid C-cell tumors. It is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or in those with MEN 2. Patients should be counseled on symptoms such as a neck mass, hoarseness, or difficulty swallowing. Review the Prescribing Information and discuss individual risk factors with a healthcare professional before use.
Programa de recompensas
Gane puntos en cumpleaños, pedidos de productos, opiniones, recomendaciones de amigos, ¡y mucho más! Disfrute de sus medicamentos con descuentos incomparables mientras cosecha recompensas por cada paso que da con nosotros.
Más información sobre las recompensas aquí.
VALOR DEL PUNTO
Cómo ganar puntos
- 1Crea una cuenta y empieza a ganar.
- 2Gane puntos cada vez que compre o realice determinadas acciones.
- 3Canjee puntos por descuentos exclusivos.
También le puede gustar
Artículos relacionados
National Diabetes Heart Connection Day—Why It Matters
Every year, millions of Americans are affected by both diabetes and heart disease, two conditions that are deeply linked but often managed separately. The American Heart Association reported that adults…
Does Ozempic Cause Insomnia? Facts You Shouldn’t Ignore
Ozempic (Semaglutide) has redefined how people approach diabetes and weight management. By helping control blood sugar levels while supporting healthy, steady weight loss, it offers a more holistic path to…
End the Scratching: How Atopica Capsules for Dogs Can Help
Constant scratching, licking, and biting are more than just annoying habits; they are signs of skin allergies or inflammation that can significantly affect a dog’s comfort and quality of life.…
Atopica Cats Medication: Relief for Itchy, Allergic Skin
When your cat constantly scratches, bites, or licks their skin, it’s not just uncomfortable for them; it can be heartbreaking to watch. Allergies in cats are more common than many…

